Defibrillator Market Size, Analysis, Trends, and Regional Forecast by 2030

According to the most recent analysis by Emergen Research The global Defibrillator Market size is expected to reach USD 26.0 Billion at a steady revenue CAGR of 9.7% in 2030, according to latest analysis by Emergen Research. Rising number of training and awareness programs on defibrillators is a major factor market revenue growth.

Despite advancements in prevention and treatment, deaths from sudden cardiac arrest account for roughly half of all deaths from cardiovascular illnesses. This is expected to spur market innovation and boost demand for both ICDs and external defibrillators. For instance, Ami Italia produces a variety of defibrillators under the Saver One, Geo, and Smarty Saver line names.

The major cause of death and disability worldwide is cardiovascular disease (CVD). 17.9 million CVD-related fatalities were reported globally in 2019, accounting for 32% of all deaths (Source: WHO). More than 75% of CVD-related fatalities take place in low- and middle-income nations. 2018 saw more than 390,000 abrupt cardiac arrests just in the US (Source: American Heart Association). Around 65% of CVD-related deaths among the entire US population occur in adults 75 and older, 29% in people 55 to 74, and 6% in people 35 to 54.

AEDs placed in public settings are occasionally vulnerable to failure because of issues with the battery, software, and hardware. If defibrillation is not performed, treatment may be delayed or even fatalities may occur. Numerous defibrillators have been recalled throughout the years as a result of technical problems with the way the device delivered shocks, electrical problems, and hardware setup. These flaws could result in poor product performance and, in some circumstances, patient death. In 2018, the FDA and Philips jointly announced the recall of certain HeartStart MRx Defibrillator units.

Get Full PDF Sampl e Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.emergenresearch.com/request-sample/1525

Key Highlights From the Report

• Over the course of the forecast period, the Implantable Cardioverter Defibrillators (ICD) segment is anticipated to hold the biggest revenue share in the global market. To detect and treat abnormal heartbeats, an ICD, a small battery-operated device, is implanted into the chest (arrhythmias). An ICD can shock the heart with electricity when necessary to restore its normal rhythm. If a person has a heart rhythm disorder (arrhythmia), such as ventricular tachycardia or ventricular fibrillation, which causes their heart to beat dangerously quickly and prevents it from pumping enough blood to the rest of their body, or if they are at a high risk of developing one, typically due to a weak heart muscle, they may need an ICD.
• Over the course of the forecast period, the category of adult patients is anticipated to provide the greatest revenue share to the global market. The sole effective treatment for ventricular fibrillation (VF), which is the most frequent cause of sudden cardiac death in adults, is electrical defibrillation. Defibrillation’s effectiveness decreases by about 10% every minute when it is postponed. Only 10.8% of adult nontraumatic cardiac arrest patients who get resuscitation from emergency medical personnel make it out of the hospital alive. When an adult patient experiences cardiac arrest at a hospital, survival rates can reach 25.5% because defibrillation is carried out more rapidly after the onset of VF, increasing the possibility that the patient will survive.

Custom Requirements can be requested for this Report [Customization Available]@ https://www.emergenresearch.com/request-for-customization/1525

Emergen Research has segmented the global soft tissue repair market on product type, application, end-use, and region:

• Type Outlook (Revenue, USD Million; 2019–2030)
  • Implantable Cardioverter Defibrillators
    1. Transvenous Implantable Cardioverter Defibrillators
       1. Biventricular ICDs/Cardiac Resynchronization Therapy Defibrillators
       2. Dual-Chamber ICDs
       3. Single-Chamber ICDs
    2. Subcutaneous Implantable Cardioverter Defibrillators
  • External Defibrillators
    1. Manual & Semi-Automated External Defibrillators
    2. Fully Automated External Defibrillators
    3. Wearable Cardioverter Defibrillators

• Patient Type Outlook (Revenue, USD Million; 2019–2030)
  • Adult Patients
  • Pediatric Patients

• End-Use Outlook (Revenue, USD Million; 2019–2030)
  • Hospitals, Clinics, and Cardiac Centers
  • Prehospital Care Settings
  • Public-Access Markets
  • Alternative Care Facilities
  • Home Care Settings
  • Other End-Use

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/defibrillator-market

• Regional Outlook (Revenue, USD Million, 2019–2030)
  • North America
    1. U.S.
    2. Canada
    3. Mexico
  • Europe
    1. Germany
    2. UK
    3. France
    4. Spain
    5. BENELUX
    6. Rest of Europe
  • Asia Pacific
    1. China
    2. India
    3. Japan
    4. South Korea
    5. Rest of APAC
  • Latin America
    1. Brazil
    2. Rest of LATAM
  • Middle East & Africa
    1. Saudi Arabia
    2. UAE
    3. Israel
    4. Rest of Middle East & Africa

Overview of Global Defibrillator Market

Defibrillators are medical devices that shock or pulse the heart with electricity to return it to normal rhythm. These are used to prevent or treat arrhythmias, which are abnormally slow or fast heartbeats. Automated external defibrillators, or AEDs, are portable, life-saving medical equipment used to treat victims of sudden cardiac arrest, a condition in which the heart stops beating abruptly and unexpectedly.

Technical Issues in Implantable and Automated External Defibrillators to Hamper Market Growth

Public Automated External Defibrillators (AEDs) are occasionally prone to malfunction because of problems with the hardware, software, or batteries. Treatment delays or even death can occur if defibrillation is not performed. In the recent years, a number of defibrillators have been recalled due to operational technical flaws, such as incorrect shock delivery, electrical problems, and hardware configuration. These defects occasionally lead to subpar product performance or even patient death.

Thank you for reading the report. The report can be customized as per the requirements of the clients. For further information or query about customization, please reach out to us, and we will offer you the report best suited for your needs.

About Us:

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkedIn | Twitter | Blogs

Latest Reports: Aerospace 3D Printing Market, Military Robots Market

Trending Reports: Medical Device Security Market, Pectin Market